Clinical Trial Update: Affects of Once-daily Oral Administration of TZP-102 on the Treatment of Symptoms Associated With Diabetic Gastroparesis [Phase 2]

View source ↗

Summary

Phase 2 trial update for TZP-102 evaluating treatment of symptoms in diabetic gastroparesis. Study status is completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Gastroparesis
• Type 1 Diabetes Mellitus
• Type 2 Diabetes Mellitus

Drugs mentioned

• TZP-102

Snippet

Sponsor: Tranzyme, Inc. | Conditions: Gastroparesis, Diabetes Mellitus, Type 1 | Phase 2 | Status: COMPLETED